Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more

Recent & Breaking News (OTCPK:NVIVQ)

InVivo Therapeutics Reports 2014 Second Quarter Financial Results and Business Update

Business Wire August 6, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in InVivo Therapeutics Holdings Corp. to Contact the Firm Before the October 6, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- NVIV

GlobeNewswire August 6, 2014

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against InVivo Therapeutics Holdings Corp.

GlobeNewswire August 5, 2014

InVivo Therapeutics CEO Mark Perrin in Featured Interview on The Wall Street Transcript

Business Wire August 5, 2014

Shapiro Haber & Urmy LLP Announces It Filed the Securities Fraud Class Action Lawsuit Against InVivo Therapeutics Holdings Corp. (NVIV)

PR Newswire August 5, 2014

INVESTOR ALERT: Class Action Lawsuit Against InVivo Therapeutics Holdings Corp. Announced by Glancy Binkow & Goldberg LLP

Business Wire August 5, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in InVivo Therapeutics Holdings Corp. to Contact the Firm Before the Lead Plaintiff Deadline in Class Action Lawsuit -- NVIV

GlobeNewswire August 4, 2014

InVivo Therapeutics Announces Posting of Management Presentation Recording from Annual Shareholders Meeting

Business Wire August 1, 2014

InVivo Therapeutics Appoints Christopher McNulty as Vice President, Business Development & Investor Relations

Business Wire July 1, 2014

InVivo Therapeutics to Present at 4th International Neural Regeneration Symposium in China

Business Wire June 30, 2014

InVivo Therapeutics Announces Barrow Neurological Institute As Third Clinical Trial Site for Neuro-Spinal Scaffold

Business Wire June 26, 2014

Advanced Cell Technology, Inc. Appoints Paul Wotton To President And CEO

Accesswire June 24, 2014

InVivo Therapeutics Announces New Responsibilities for Senior Management Team Members

Business Wire June 24, 2014

InVivo Therapeutics Announces Realignment of R&D Strategy

Business Wire June 23, 2014

InVivo Therapeutics Appoints Steven McAllister as CFO

Business Wire June 19, 2014

OncoSec Medical Inc. To Be Featured Presenter At 3rd Annual Marcum MicroCap Conference

Accesswire May 16, 2014

InVivo Therapeutics Announces Its Second Clinical Study Site for Neuro-Spinal Scaffold

Business Wire May 14, 2014

InVivo Therapeutics Reports 2014 First Quarter Financial Results and Business Update

Business Wire May 12, 2014

InVivo Therapeutics Holdings Corp. Closes Public Offering of Common Stock and Warrants

Business Wire May 9, 2014

InVivo Therapeutics Holdings Corp. Announces Pricing of Public Offering of Common Stock and Warrants

Business Wire May 6, 2014